Our observations on RAC1B-TGFβ signaling cross-talk have been mostly made in cancer cells with a well-to-moderately differentiated phenotype and a poor-to-moderately invasive potential, because only these express sufficient amounts of RAC1B. This evidence concerns the gene TGFB1 and cancer.